With an aim to raise funds to expand its clinics business, Apollo Hospitals will dilute some stake in the vertical for Rs 450 crore this fiscal, a top company official said on Tuesday.
Reliance Securities said the Ebitda margins will continue to be under pressure on account of increased R&D spending and adverse product-mix.
Glenmark Pharmaceuticals has appointed Kurt Stoeckli as President and Chief Scientific Officer (CSO) of the company.
Drug firms Boehringer Ingelheim and Lupin have entered into a partnership to co-market Empagliflozin used for treatment of type 2 diabetes in India.
Cipla said it has received an establishment inspection report from the US Food and Drug Administration for its Indore plant after completion of inspection there.
As part of the integration of erstwhile Ranbaxy, it was decided to use Target Application as a single platform for DAR for the India field force, Sun Pharma said.
As part of the integration of erstwhile Ranbaxy, it was decided to use Target Application as a single platform for DAR for the India field force, Sun Pharma added.
The recall has been initiated by Sun Pharmaceutical Industries Inc for 31,762 bottles of bupropion hydrochloride extended-release tablets, USP (SR) in the strength of 150 mg, the US drug regulator said.
Dr Reddy's Laboratories said its product is a generic version of GSK Group of companies' Lamictal tablets.
With substantial investments of Rs 106 crore in R&D in 2015-16, use of latest platform technologies and developing niche and complex formulations, Ajanta Pharma is confident of reinforcing its exclusive positioning in the markets it operates in.
Currently, Dr Reddy's is the second largest generic oncology injectable company by value in the US and leading generic oncology firm in India.
The price range equates to a discount of between 3.1 per cent and 5.5 per cent of Wednesday closing price of Rs 856.85 ($12.83).
Cadila Healthcare said Grafalon offers a specific advantage of efficacy and better safety profile through targeted immunosuppression.
The tablets have been manufactured at the company's Goa facility. A single bottle contains 500 tablets of the medicine.
AstraZeneca will get $30 million in upfront fees and $120 million in various milestone payments, Insmed said.
Jubilant Life Sciences on Tuesday said its wholly-owned subsidiary has received approval from the Australian health regulator Therapeutic Goods Administration (TGA) for Lyophilized kit for preparation of injection used for lungs scan.
Wockhardt said the FDA had on September 30, 2016 posted on its website an update on the Import Alert 66-40 "regarding company's API Unit at Ankleshwar".
To ensure availability of essential drugs in the market, the National Pharmaceutical Pricing Authority (NPPA) is putting in place a framework for alternative arrangements in case of discontinuation of scheduled formulations by private pharmaceutical firms, among other measures.
Biologics, manufactured in living cells, then extracted and purified, are more complex than traditional medicines and cannot be copied with precision, and so their knock-off versions are called biosimilars instead of generics.
Drug companies are facing a tough environment due to the government bringing more products under the price control policy as also tightening of registration procedure that has impacted time to market newer products, Cipla chairman Y K Hamied has said.